title: Combination of rapamycin and imatinib in treating refractory chronic myeloid leukemia myeloid blast crisis:a case report(025B3;).
authors.affiliation: Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China.
authors.forename: Jing
authors.initials: J
authors.lastname: Xie
authors.forename: Xiang
authors.initials: X
authors.lastname: Zhang
authors.forename: Bao-zhi
authors.initials: BZ
authors.lastname: Fang
authors.forename: Guang-sheng
authors.initials: GS
authors.lastname: He
authors.forename: Yun
authors.initials: Y
authors.lastname: Zhao
authors.forename: De-pei
authors.initials: DP
authors.lastname: Wu
mesh_terms: D000328:Adult; D001549:Benzamides / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D020123:Sirolimus